Report

  1. Home
  2. Tech & Telecoms
  3. Technology

Artificial Intelligence in Drug Discovery Market Research Report Forecast to 2030

Market Report I 2023-09-01 I 132 Pages I Market Research Future

Artificial Intelligence in Drug Discovery Market Research Report Forecast to 2030

Market Overview
The Artificial Intelligence in Drug Discovery Market is anticipated to register a substantial CAGR of 29.83% during the forecast period. The increasing reception of simulated intelligence in drug discovery, rising key initiatives for man-made intelligence in drug discovery, and the increasing number of man-made intelligence-powered drug discovery new companies are driving business sector development.
The reception of simulated intelligence in drug discovery is rising among industries, including drug and biotechnology organizations. This is essentially owing to the way that artificial intelligence offers progressed benefits to discovering drug particles and paces up the drug discovery process. Further, artificial intelligence gives significant insights to work on the designing, optimizing, and synthesizing of drugs. There are a few factors that are increasing the reception of man-made intelligence for drug discovery. The absolute most predominant ones include the rising incidences of ongoing illnesses and accuracy medicine, owing to the emerging way to deal with the counteraction and treatment of sicknesses. Besides, a few market members are increasing the accuracy of their drug portfolios, a cycle that has been seen to exhibit an increase in the reception of man-made intelligence advancements.
Market Segmentation
Based on product and service Artificial Intelligence in Drug Discovery, is classified into software and services. Based on a molecule type the market is divided into large molecules and small molecules. The Market of Artificial Intelligence in Drug Discovery based on technology is divided into machine learning, deep learning, and others.
Based on an indication the market is classified into immuno-oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases, and others. Based on an application the market is categorized into target identification, candidate screening, de novo drug designing, drug optimization and repurposing, and preclinical testing.
Regional Insights
The North American artificial intelligence in the drug discovery market represented the biggest piece of the pie in 2022. This is because of the increasing incidences of ongoing illnesses, many leading new companies, and increasing drug Research and development investments in the region.
Europe's artificial intelligence in the drug discovery market represents the second-biggest piece of the pie because of the rising pervasiveness of uncommon illnesses across Europe and increasing the demand for a simulated intelligence-driven stage for drug discovery. Moreover, Germany's market of artificial intelligence
The Asia-Pacific artificial intelligence in drug discovery market is supposed to develop at a huge offer from 2023 to 2030. This is because of the rising weight of sickness and the tremendous number of biopharmaceutical industries that are adopting computer-based intelligence abilities in the Asia-Pacific region.
The rest of the World is fragmented into the Center East, Africa, and Latin America. Artificial intelligence in the drug discovery market in the previously mentioned regions is probably going to observe development because of the increasing demand for drugs because of the rising incidences of persistent and infectious illnesses.
Major Players
Key Companies in the Artificial Intelligence in Drug Discovery Market include IBM (US), Alphabet Inc (US), Atomwise Inc (US), Deep Genomics (Canada), Cloud Pharmaceuticals, Inc (US), Microsoft corporation (US), Insilico Medicine (China), Cyclica (Canada), BenevolentAI (UK), and Exscientia (UK).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

3.1 OVERVIEW

3.2 DATA MINING

3.3 SECONDARY RESEARCH

3.4 PRIMARY RESEARCH

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING ADOPTION OF AI IN DRUG DISCOVERY

4.2.2 RISING STRATEGIC INITIATIVES FOR AI IN DRUG DISCOVERY

4.2.3 INCREASING NUMBER OF AI-POWERED DRUG DISCOVERY START-UPS

4.3 RESTRAINTS

4.3.1 SHORTAGE OF AI WORKFORCE

4.4 OPPORTUNITIES

4.4.1 EMERGING MARKETS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL AI IN DRUG DISCOVERY

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON SERVICE DEMAND

5.3.3 IMPACT ON MARKET PLAYERS

6 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT AND SERVICE

6.1 OVERVIEW

6.2 SOFTWARE

6.3 SERVICES

7 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE

7.1 OVERVIEW

7.2 LARGE MOLECULE

7.3 SMALL MOLECULE

8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 MACHINE LEARNING

8.3 DEEP LEARNING

8.4 OTHERS

9 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION

9.1 OVERVIEW

9.2 IMMUNO-ONCOLOGY

9.3 NEURODEGENERATIVE DISEASES

9.4 CARDIOVASCULAR DISEASES

9.5 METABOLIC DISEASES

9.6 OTHERS

10 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 TARGET IDENTIFICATION

10.3 CANDIDATE SCREENING

10.4 DE NOVO DRUG DESIGNING

10.5 DRUG OPTIMIZATION AND REPURPOSING

10.6 PRECLINICAL TESTING

11 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.2.1 US

11.2.2 CANADA

11.3 EUROPE

11.3.1 GERMANY

11.3.2 FRANCE

11.3.3 UK

11.3.4 ITALY

11.3.5 SPAIN

11.3.6 REST OF EUROPE

11.4 ASIA-PACIFIC

11.4.1 CHINA

11.4.2 JAPAN

11.4.3 INDIA

11.4.4 AUSTRALIA

11.4.5 SOUTH KOREA

11.4.6 REST OF ASIA-PACIFIC

11.5 REST OF THE WORLD

11.5.1 MIDDLE EAST

11.5.2 AFRICA

11.5.3 LATIN AMERICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW

12.2 COMPETITIVE BENCHMARKING

12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL AI IN DRUG DISCOVERY MARKET

12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET

12.5 KEY DEVELOPMENT ANALYSIS

12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

12.6.1 SERVICE/COMPANY LAUNCH

12.6.2 MERGER/ACQUISITION

12.6.3 PARTNERSHIP/COLLABORATION/AGREEMENT

13 COMPANY PROFILES

13.1 IBM

13.1.1 COMPANY OVERVIEW

13.1.2 FINANCIAL OVERVIEW

13.1.3 SOFTWARE/SERVICES OFFERED

13.1.4 KEY DEVELOPMENTS

13.1.5 SWOT ANALYSIS

13.1.6 KEY STRATEGIES

13.2 ALPHABET INC.

13.2.1 COMPANY OVERVIEW

13.2.2 FINANCIAL OVERVIEW

13.2.3 SOFTWARE/SERVICES OFFERED

13.2.4 KEY DEVELOPMENTS

13.2.5 SWOT ANALYSIS

13.2.6 KEY STRATEGIES

13.3 ATOMWISE INC.

13.3.1 COMPANY OVERVIEW

13.3.2 FINANCIAL OVERVIEW

13.3.3 SOFTWARE/SERVICES OFFERED

13.3.4 KEY DEVELOPMENTS

13.3.5 SWOT ANALYSIS

13.3.6 KEY STRATEGIES

13.4 DEEP GENOMICS

13.4.1 COMPANY OVERVIEW

13.4.2 FINANCIAL OVERVIEW

13.4.3 SOFTWARE/SERVICES OFFERED

13.4.4 KEY DEVELOPMENTS

13.4.5 KEY STRATEGIES

13.5 CLOUD PHARMACEUTICALS, INC.

13.5.1 COMPANY OVERVIEW

13.5.2 FINANCIAL OVERVIEW

13.5.3 SOFTWARE/SERVICES OFFERED

13.5.4 KEY DEVELOPMENTS

13.5.5 KEY STRATEGIES

13.6 MICROSOFT CORPORATION

13.6.1 COMPANY OVERVIEW

13.6.2 FINANCIAL OVERVIEW

13.6.3 SERVICES OFFERED

13.6.4 KEY DEVELOPMENTS

13.6.5 SWOT ANALYSIS

13.6.6 KEY STRATEGIES

13.7 INSILICO MEDICINE

13.7.1 COMPANY OVERVIEW

13.7.2 FINANCIAL OVERVIEW

13.7.3 SERVICES OFFERED

13.7.4 KEY DEVELOPMENTS

13.7.5 KEY STRATEGIES

13.8 CYCLICA

13.8.1 COMPANY OVERVIEW

13.8.2 FINANCIAL OVERVIEW

13.8.3 SERVICES OFFERED

13.8.4 KEY DEVELOPMENTS

13.8.5 KEY STRATEGIES

13.9 BENEVOLENTAI

13.9.1 COMPANY OVERVIEW

13.9.2 FINANCIAL OVERVIEW

13.9.3 SERVICES OFFERED

13.9.4 KEY DEVELOPMENTS

13.9.5 SWOT ANALYSIS

13.9.6 KEY STRATEGIES

13.10 EXSCIENTIA

13.10.1 COMPANY OVERVIEW

13.10.2 FINANCIAL OVERVIEW

13.10.3 SOFTWARES OFFERED

13.10.4 KEY DEVELOPMENTS

13.10.5 KEY STRATEGIES

14 APPENDIX

14.1 REFERENCES

14.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 3 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR PRODUCT, BY REGION, 2019-2030 (USD BILLION)

TABLE 4 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR SERVICES, BY REGION, 2019-2030 (USD BILLION)

TABLE 5 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 6 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR LARGE MOLECULE, BY REGION, 2019-2030 (USD BILLION)

TABLE 7 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR SMALL MOLECULE, BY REGION, 2019-2030 (USD BILLION)

TABLE 8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 9 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR MACHINE LEARNING, BY REGION, 2019-2030 (USD BILLION)

TABLE 10 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DEEP LEARNING, BY REGION, 2019-2030 (USD BILLION)

TABLE 11 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)

TABLE 12 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 13 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR IMMUNO-ONCOLOGY, BY REGION, 2019-2030 (USD BILLION)

TABLE 14 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR NEURODEGENERATIVE DISEASES, BY REGION, 2019-2030 (USD BILLION)

TABLE 15 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2019-2030 (USD BILLION)

TABLE 16 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR METABOLIC DISEASES, BY REGION, 2019-2030 (USD BILLION)

TABLE 17 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)

TABLE 18 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 19 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR TARGET IDENTIFICATION, BY REGION, 2019-2030 (USD BILLION)

TABLE 20 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR CANDIDATE SCREENING, BY REGION, 2019-2030 (USD BILLION)

TABLE 21 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DE NOVO DRUG DESIGNING, BY REGION, 2019-2030 (USD BILLION)

TABLE 22 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR DRUG OPTIMIZATION AND REPURPOSING, BY REGION, 2019-2030 (USD BILLION)

TABLE 23 GLOBAL AI IN DRUG DISCOVERY MARKET, FOR PRECLINICAL TESTING, BY REGION, 2019-2030 (USD BILLION)

TABLE 24 GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION, 2019-2030 (USD BILLION)

TABLE 25 NORTH AMERICA: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2030 (USD BILLION)

TABLE 26 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 27 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 28 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 29 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 30 NORTH AMERICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 31 US AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 32 US AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 33 US AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 34 US AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 35 US AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 36 CANADA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 37 CANADA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 38 CANADA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 39 CANADA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 40 CANADA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 41 EUROPE: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2030 (USD BILLION)

TABLE 42 EUROPE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 43 EUROPE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 44 EUROPE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 45 EUROPE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 46 EUROPE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 47 GERMANY AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 48 GERMANY AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 49 GERMANY AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 50 GERMANY AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 51 GERMANY AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 52 FRANCE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 53 FRANCE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 54 FRANCE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 55 FRANCE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 56 FRANCE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 57 UK AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 58 UK AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 59 UK AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 60 UK AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 61 UK AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 62 ITALY AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 63 ITALY AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 64 ITALY AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 65 ITALY AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 66 ITALY AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 67 SPAIN AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 68 SPAIN AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 69 SPAIN AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 70 SPAIN AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 71 SPAIN AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 72 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 73 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 74 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 75 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 76 REST OF EUROPE AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 77 ASIA-PACIFIC: AI IN DRUG DISCOVERY MARKET, BY COUNTRY, 2018-2030 (USD BILLION)

TABLE 78 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 79 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 80 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 81 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 82 ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 83 CHINA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 84 CHINA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 85 CHINA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 86 CHINA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 87 CHINA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 88 JAPAN AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 89 JAPAN AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 90 JAPAN AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 91 JAPAN AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 92 JAPAN AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 93 INDIA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 94 INDIA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 95 INDIA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 96 INDIA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 97 INDIA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 98 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 99 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 100 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 101 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 102 AUSTRALIA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 103 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 104 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 105 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 106 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 107 SOUTH KOREA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 108 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 109 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 110 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 111 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 112 REST OF ASIA-PACIFIC AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 113 REST OF THE WORLD: AI IN DRUG DISCOVERY MARKET, BY REGION, 2018-2030 (USD BILLION)

TABLE 114 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 115 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 116 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 117 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 118 REST OF THE WORLD AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 119 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 120 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 121 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 122 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 123 MIDDLE EAST AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 124 AFRICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 125 AFRICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 126 AFRICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 127 AFRICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 128 AFRICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 129 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2019-2030 (USD BILLION)

TABLE 130 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2019-2030 (USD BILLION)

TABLE 131 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2030 (USD BILLION)

TABLE 132 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2019-2030 (USD BILLION)

TABLE 133 LATIN AMERICA AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2019-2030 (USD BILLION)

TABLE 134 MAJOR PLAYERS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET

TABLE 135 MOST ACTIVE PLAYER IN THE GLOBAL AI IN DRUG DISCOVERY MARKET

TABLE 136 SERVICE/COMPANY LAUNCH

TABLE 137 MERGER/ACQUISITION

TABLE 138 PARTNERSHIP/COLLABORATION/AGREEMENT

TABLE 139 IBM: SOFTWARE/SERVICES OFFERED

TABLE 140 IBM: KEY DEVELOPMENTS

TABLE 141 ALPHABET INC.: SOFTWARE/SERVICES OFFERED

TABLE 142 ALPHABET INC.: KEY DEVELOPMENTS

TABLE 143 ATOMWISE INC.: SOFTWARE/SERVICES OFFERED

TABLE 144 ATOMWISE INC.: KEY DEVELOPMENTS

TABLE 145 DEEP GENOMICS: SOFTWARE/SERVICES OFFERED

TABLE 146 CLOUD PHARMACEUTICALS, INC.: SOFTWARE/SERVICES OFFERED

TABLE 147 CLOUD PHARMACEUTICALS, INC.: KEY DEVELOPMENTS

TABLE 148 MICROSOFT CORPORATION: SERVICES OFFERED

TABLE 149 INSILICO MEDICINE: SERVICES OFFERED

TABLE 150 CYCLICA: SERVICES OFFERED

TABLE 151 BENEVOLENTAI: SERVICES OFFERED

TABLE 152 EXSCIENTIA: SOFTWARES OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL AI IN DRUG DISCOVERY MARKET STRUCTURE

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE AI IN DRUG DISCOVERY

FIGURE 4 DRIVER IMPACT ANALYSIS

FIGURE 5 RESTRAINT IMPACT ANALYSIS

FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL AI IN DRUG DISCOVERY

FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL AI IN DRUG DISCOVERY

FIGURE 8 GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT & SERVICE, 2022 & 2030 (USD BILLION)

FIGURE 9 GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE, 2022 & 2030 (USD BILLION)

FIGURE 10 GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2022 & 2030 (USD BILLION)

FIGURE 11 GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION, 2022 & 2030 (USD BILLION)

FIGURE 12 GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION, 2022 & 2030 (USD BILLION)

FIGURE 13 GLOBAL AI IN DRUG DISCOVERY MARKET: BY REGION, 2022 & 2030 (USD BILLION)

FIGURE 14 GLOBAL AI IN DRUG DISCOVERY MARKET SHARE (%), BY REGION, 2022

FIGURE 15 NORTH AMERICA: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 16 EUROPE: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 17 ASIA-PACIFIC: AI IN DRUG DISCOVERY MARKET SHARE (%), BY COUNTRY, 2022

FIGURE 18 REST OF THE WORLD: AI IN DRUG DISCOVERY MARKET SHARE (%), BY REGION, 2022

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL AI IN DRUG DISCOVERY MARKET

FIGURE 21 GLOBAL AI IN DRUG DISCOVERY MARKET: COMPETITIVE LANDSCAPE

FIGURE 22 IBM: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 IBM: SWOT ANALYSIS

FIGURE 24 ALPHABET INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 ALPHABET INC.: SWOT ANALYSIS

FIGURE 26 ATOMWISE INC.: SWOT ANALYSIS

FIGURE 27 MICROSOFT CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 MICROSOFT CORPORATION: SWOT ANALYSIS

FIGURE 29 BENEVOLENTAI: SWOT ANALYSIS

FIGURE 30 EXSCIENTIA: FINANCIAL OVERVIEW SNAPSHOT

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE

Related Reports

Cloud Storage Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Private, Public, Hybrid), By Storage Type (File Storage, Object Storage, Block Storage), By Application (BFSI, IT & Telecommunication, Government & Public Sector, Manufacturing, Healthcare & Life Sciences, Retail & Consumer Goods, Media & Entertainment, Others), By Region & Competition, 2020-2030F
 Market Report I 2025-06-13 I 188 Pages
IoT in Education Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Component (Hardware, Software, Services, Platforms), By Application (Smart Classrooms, Learning Management Systems, Virtual Labs, Student Attendance Management, Performance Tracking), By End User (K-12 Schools, Higher Education Institutions, Vocational Training Centers, Corporate Training), By Region, By Competition 2020-2030F
 Market Report I 2025-06-13 I 185 Pages
Smart Hospitality Market - Global Industry Size, Share, Trends, Opportunity, And Forecast, Segmented By Offering (Solutions, Services), By Deployment Mode (Cloud, On-premises), By End User (Hotel, Cruise, Luxury Yatches, Others), By Region & Competition, 2020-2030F
 Market Report I 2025-06-13 I 185 Pages

Don't forget we can help save time with your search, contact us and we'll prepare and send options

IoT Connectivity Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Component (Platform, Services), By Application (Building & Home Automation, Smart Energy & Utility, Smart Manufacturing, Connected Health, Smart Retail, Smart Transportation, Others), By Organization Size (Large Enterprises, SMEs), By Region & Competition, 2020-2030F
 Market Report I 2025-06-13 I 185 Pages
Security Risk Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Solutions, Services), By Solutions (Financial risk management, Compliance risk management, Cybersecurity risk management, Enterprise risk management, Operational risk management, Others), By Services (Consulting & advisory, Integration & deployment, Support & maintenance, Managed services), by Deployment Model (On-Premise, Cloud-Based), By Organization Size (Large Enterprises, Small and Medium Enterprises (SMEs)), By Industry Vertical (BFSI, IT and Telecom, Government and Defense, Healthcare, Energy and Utilities, Retail and E-commerce, Manufacturing, Transportation and Logistics, Others), By Region & Competition, 2020-2030F
 Market Report I 2025-06-13 I 185 Pages